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Abstract The next major steps in human spaceflight
include flyby, orbital, and landing missions to the Moon,
Mars, and near earth asteroids. The first crewed deep space
mission is expected to launch in 2022, which affords less
than 7 years to address the complex question of whether
and how to apply artificial gravity to counter the effects of
prolonged weightlessness. Various phenotypic changes are
demonstrated during artificial gravity experiments. How-
ever, the molecular dynamics (genotype and molecular
phenotypes) that underlie these morphological, physiolog-
ical, and behavioral phenotypes are far more complex than
previously understood. Thus, targeted molecular assess-
ment of subjects under various G conditions can be
expected to miss important patterns of molecular variance
that inform the more general phenotypes typically being
measured. Use of omics methods can help detect changes
across broad molecular networks, as various G-loading
paradigms are applied. This will be useful in detecting off-
target, or unanticipated effects of the different gravity
paradigms applied to humans or animals. Insights gained
from these approaches may eventually be used to inform
countermeasure development or refine the deployment of
existing countermeasures. This convergence of the omics
and artificial gravity research communities may be critical
if we are to develop the proper artificial gravity solutions
under the severely compressed timelines currently estab-
lished. Thus, the omics community may offer a unique
ability to accelerate discovery, provide new insights, and
benefit deep space missions in ways that have not been
previously considered.
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1 Introduction
According to NASA’s flexible deep space exploration path,
the next major steps in human spaceflight include flyby and
orbital missions to the Moon, Mars, near earth asteroids,
lunar and Martian landings, and combinations of these
scenarios (Paloski et al. 2014). The first crewed private
deep space mission is expected to launch in 2022 (Inspi-
ration Mars; Clyne 2014; Mooring 2013), followed by the
Mars One Mission in 2024 (Sewell 2012). This affords less
than 7 years to sufficiently answer one of the most pressing
questions related to human safety and performance, and to
pass these data on to spacecraft designers. That is, what is
the true benefit of an artificial gravity (AG) regime and
how do we best validate its efficacy? Answering such
questions will require discovery methods that can
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accommodate these accelerated timelines and handle the
requisite complexity that investigators will most certainly
encounter.
2 Background: gravity on earth and in space
The incompletely defined, but inevitable, adverse effects of
30-months exposure to reduced gravity during a Mars
mission (0 G during transit and 0.38 G, while on the
planetary surface) are not likely to be remedied by exer-
cise, pharmaceuticals, or a combination of both (Paloski
et al. 2014). The reasons for their failure are predictable.
Ever since the Late Devonian period, 375 million years
ago, when primitive vertebrates first migrated from the
buoyancy of the ancient sea onto land, all life forms on
Earth have had to evolve adaptive mechanisms to contend
with the unremitting and ubiquitous ‘‘force’’ of gravity.
The complex constellation of hormonal, reflex, and central
nervous system adaptive changes that enable humans to
maintain a bipedal posture in three dimensional space are
dependent on the presence of the gravitational acceleration
vector for stimulation and orientation. When the gravita-
tional umbilical cord is severed to allow human space
travel, these adaptive mechanisms become maladaptive,
leading to dysfunctional changes—particularly in the car-
diovascular, musculoskeletal, and vestibular systems.
None of the present countermeasures can replace the
unique features and effects of gravity, which is the missing
critical ingredient. But there is growing promise that ‘‘ar-
tificial’’ gravity (AG) can do so. ‘‘Artificial gravity’’ is a
tolerable misnomer that refers to the centripetal accelera-
tion forces and resulting inertia that are imposed on a
human who is exposed to continuous radial motion in a
centrifuge. Although centrifugal forces during a centrifu-
gation as the product of artificial gravity generation show
large gravity gradients along their lines of action (e.g. 0.2
G in the region of the head and 2 G in the region of the
calves on a short arm centrifuge when the subject is posi-
tioned in ?Gz direction), centrifugation is, nevertheless,
the application that comes closest to real gravity (Cle´ment
et al. 2015).
It is fortuitous for future space voyagers that, in accor-
dance with Einstein’s ‘Theory of Equivalence,’ the human
body cannot distinguish between the effects of accelera-
tions generated by gravitation or by centrifugation (though
effects of the Coriolis force must be considered). It
responds identically to both, at the cellular, systemic, and
behavioral levels.
Just as it is now critical for the space traveler to carry
along sufficient oxygen, food, water, and ambient pressure
to sustain life, AG offers the promise of a ‘‘portable’’
gravity equivalent that can prevent the harmful effects of
prolonged exposure to ‘‘weightlessness’’ and minimize the
adjustments required to return to, and function within,
earth’s 1 G environment or partial gravities, such as the
Moon (0.17 G) and Mars (0.38 G).
The role of AG is one of the many challenges con-
fronting space researchers and it compels us to address at
least two seminal points. First, the degree to which AG is
an effective countermeasure against the detrimental effects
of prolonged space flight, must be established. Second, if
deemed an effective countermeasure, we must design an
optimal prescription for its use. Should exposure to AG be
continuous or intermittent? Should AG be deployed only
during sleep or periodically throughout the day? What is
the optimal duration for the application of AG? At what
intensity (G load) should AG be applied for a given space
condition or environment?
The application of artificial gravity requires spinning the
space vehicle (or a component thereof) during any pro-
longed exposure to weightlessness (Fig. 1). Recently, the
Artificial Gravity Working Group (AGWG) agreed that this
was needed, though the optimum parameters for such
applications are not yet well defined. Moreover, answering
these most fundamental questions with precision has sig-
nificant engineering, biomedical, and cost implications.
NASA and private industry are exploring more than nine
design reference missions (DRMs) to send humans into
deep space for long-duration periods (years). AG and
gravity-based research programs encompassing animal
investigations on the International Space Station, and short-
and long-radius centrifugation of humans on the ground are
either being initiated, or have previously been conducted
by NASA and the research community. This will be used to
identify the specific gaps associated with possible AG
profiles and perform trade-off feasibility analyses between
potential AG profiles and non-AG solutions (Paloski et al.
Fig. 1 Artificial gravity rotating wheel model. The rotating wheel
(right) affixed to the Nautilus-X spacecraft design is one conception
of how artificial gravity might be applied. Understanding the scale,
rate of rotation, radius length, and specific artificial gravity param-
eters will be central to achieving successful mission AG profiles.
(Image: NASA)
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2014; Young et al. 2009; Johnson et al. 1997). Given the
compressed timeline of only 7 years to better answer key
AG questions, we propose that an omics-based approach be
considered for all artificial gravity research, with the intent
to accelerate our understanding of the human response to
AG under these compressed mission time lines.
3 Understanding the molecular landscape beneath
the AG phenotype
Various phenotypic changes are demonstrated during arti-
ficial gravity experiments. The general phenotypes under
observation are typically characterized as morphological,
physiological, and behavioral. In such studies, attention is
given to a broad range of measurement methods, which
frequently includes targeted molecular profiling. This
approach has been informative for some decades.
However, the molecular dynamics (genotype and
molecular phenotypes) that underlie these morphological,
physiological, and behavioral phenotypes are far more
complex than previously understood (Fig. 2). Thus, tar-
geted molecular assessment of subjects under various G
conditions can be expected to miss important patterns of
molecular variance that inform the more general pheno-
types typically being measured. To better understand this
dynamic, it is useful to explore some of the artificial
gravity work that exists, the status of molecular profiling to
date, and the frontier of omics applications in AG research.
4 Targeted molecular assessment in space
and on earth
There are a limited number of study paradigms with which
to study artificial gravity conditions, most of which involve
centrifugation. Among the primary study paradigms are,
(1) humans, animals, tissues, or cells subjected to cen-
trifugation, while in space; (2) humans, animals, tissues, or
cells on earth exposed to hypergravity conditions, which
use earth gravity (1 G) as a control compared with varying
degrees of elevated G forces applied through centrifuga-
tion; (3) Head up or head down bed rest studies (short,
intermediate, long duration), coupled with centrifugation;
4) Limb suspension studies with centrifugation, and 5)
others (Tables 1 and 2). For the purpose of this review, we
will focus on the limited number of studies in humans,
animals, tissues, or cells in the in-flight (0G-AG?) or
Earth-based (1G-AG?) condition (Table 3).
4.1 Targeted molecular profiling and AG in space
To our knowledge, there is only one in-flight evaluation of
artificial gravity on astronauts. This study explored the
vestibular responses to linear accelerations, using a human-
rated centrifuge chair aboard the Space Shuttle Neurolab
mission (STS-90) in 1998. Four payload crewmembers
were exposed to in-flight 1 G centripetal acceleration
generated by a centrifuge, with two crewmembers also
exposed to 0.5 G centrifugation in-flight. The results of this
Fig. 2 Molecular landscape that underlies the morphological, phys-
iological, and behavioral phenotype. The progression from genome to
phenotype is shown above (left to right), representing the extraordi-
nary complexity of this landscape. Numbers in parentheses represent
the estimated number of unique molecular forms found in each
subdomain. Measurement in artificial gravity experiments frequently
occurs at the physiological, morphological, and behavioral levels.
Targeted components of the molecular landscape (limited, selected
chemistry profiles) are also sometimes measured under different
gravity exposure paradigms, though they represent a small snapshot
of the whole. The application of omics to artificial gravity experi-
ments today is quite limited, representing an enormous opportunity to
clarify biological responses and advance the field. (Image: Sovaris
Aerospace) (Adapted from Gerszten and Wang 2008)
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experiment suggested that centrifugal force of 0.5 and 1 G
along the subjects’ longitudinal and transversal axis,
respectively, was well tolerated by the crew (Cle´ment et al.
2001). For those astronauts who rode the centrifuge 20 min
every other day during a 16-day space mission,
cardiovascular deconditioning was reduced, while otolith-
ocular reflexes were preserved during and after flight
(Moore et al. 2005).
To date, there exist only two studies of animals flown in
space and subjected to artificial gravity. These were part of
the Soviet Cosmos missions conducted in the 1970s. The
first animals to be centrifuged in space were flown on the
20-day Cosmos-782 mission in 1975. Fish and turtles were
housed in containers and centrifuged at 1 G, during the
20 day 0 G exposure. The center of the containers was
placed at 37.5 cm from the center of a platform rotating at
52 rpm. Post-flight behavior and physiology were compa-
rable to animals at 1 G. Turtles centrifuged at levels as low
as 0.3 G showed none of the muscle wasting typically
associated with microgravity (Ilyin and Parfenov 1979).
A more extensive investigation was conducted during
the 19-day Cosmos-936 mission in 1977. Twenty-five
unrestrained male Wistar rats were kept in individual cages
Table 1 Space-based partial gravity analogues
Name of analogue Species suitability Exposure duration References
Short-radius human centrifugation Human Acute Cle´ment and Slenzka (2006)
Long-radius human centrifugation Human Chronic Cle´ment et al. (2001) and Cle´ment (2015)
Long-radius human centrifugation Animal Chronic Cle´ment and Slenzka (2006)
Rotating wall vessel (RWV) Cells or tissue cultures Chronic Ruoxiang et al. (2005); Goodwin et al. (2004);
Kleis et al. (2005); Becker and Souza (2013)
Table 2 Earth-based partial and microgravity analogues
Name of analogue Species suitability Exposure
duration
References
Parabolic flight Human Acute Pletser et al. (2012)
Head-up tilt Human Acute Cavanagh et al. (2013)
Supine or head-down tilted short-radius centrifugation Human Acute Cle´ment et al. (2015); Young and Paloski
(2007); Greenleaf et al. (1996)
Whole-body weighted garment water immersion Human Acute Johansen et al. (1998),
Lower body positive pressure Human Acute McNeill et al. (2015)
Overhead suspension Human Acute Ellman et al. (2013); Norcross et al. (2010a,
b, 2012)
Head-out graded water immersion Human Acute Regnard et al. (2001)
Head-out graded dry immersion Human Chronic Navasiolava et al. (2011)




Graybiel et al. (1960, 1965); van Loon (2009)
Head-up bedrest Human Chronic Pavy-Le Traon et al. (1997); Louisy et al.
(1994)
Computational modeling Human, animal Acute or
chronic
Pennline and Mulugeta (2014)
Animal suspension Animal Chronic Gaignier et al. (2014)
Rotating wall vessel (RWV) Cells or tissue
cultures
Chronic Tsao et al. (1992); Becker and Souza (2013)
Table 3 Experimental conditions employed in partial and micro-
gravity investigations
Gravitational context Gravity condition Species/specimen
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and placed in a centrifuge with a radius of 32 cm. An
artificial gravity level of 1 G was obtained by spinning the
centrifuge at 53.5 rpm.
Compared to animals in microgravity that were not
exposed to AG, in-flight centrifugation had a protective
effect on the musculoskeletal system and myocardium.
However, animals exposed to in-flight AG experienced
visual, motor, and vestibular adverse effects, including
altered equilibrium, righting reflex, and orientation disor-
ders. These effects were presumably due to the magnitude
of the gravity gradient and the high rotation rate of the
centrifuge (Gurovsky et al. 1980).
It is important to note that neither the single in-flight
human AG study conducted in 1998 nor the two in-flight
animal AG studies (1975, 1977) sought to analyze molec-
ular markers in urine, blood, or tissues. Thus, we presently
have little understanding of the molecular dynamics when
AG is applied to humans or animals, during space flight—
the most representative of the AG study paradigms.
Therefore, we must rely upon surrogate experiments on
bacteria, cells, and other biological specimens. These have
been flown on the shuttle’s Spacelab, and in the Mir, Sal-
yut, and Skylab space stations. While extensive molecular
profiling is still limited, results indicate that microgravity
effects at the cellular level can be substantially reduced by
AG (Cle´ment and Slenzka 2006).
The only active or planned human or animal space-
based AG studies of which we are aware are sponsored by
the Japan Aerospace Exploration Agency (JAXA) and
NASA, respectively. The facility for the JAXA animal AG
study is now on board the ISS, with proposed experimen-
tation to be completed in 2016. This is a modified cell
biology centrifuge with a relatively short arm (15 cm
radius) that can operate at a rotation rate of 77 rpm. Six
mice will be exposed to 1 G for 1–6 months, while six
other mice will live at 0 G for the same duration (J.
Robinson, personal communications, August 25, 2015).
The study will have to be closely watched, given that
previous work (Cosmos-936) with a short radius centrifuge
induced significant side effects from the relatively high
rotational speed.
NASA is currently funding the development of a Rodent
Centrifuge Facility (RCF), which will accommodate as
many as 14 modular rodent cages. These can be cus-
tomized to house 42 mice or 28 rats. The facility will be
designed for providing continuous centrifugal force of
0.16, 0.38, 0.66, and 1 G for a minimum of 30 days of
unattended operation, though it will be able to accommo-
date experiments lasting up to 90 days.
4.2 Targeted molecular profiling and AG on earth
Targeted molecular studies of humans comparing in-flight
0 G to artificial 1 G are difficult, since the technical
infrastructure for applying 1 G centrifugation of humans in
the microgravity environment of space does not presently
exist. So, various G parameters (2 G, 3 G, etc.) have been
applied to humans at 1 G earth gravity to examine for
molecular variance between the different G conditions. For
the purpose of this review, we have limited our examina-
tion to selective representative studies of up to 3 G.
Schneider et al. examined 11 participants who under-
went 15 min acceleration to 3 Gz. The following stress-
associated small molecules increased in comparison to
controls: Serum cortisol 70 %; plasma ACTH three-fold;
prolactin two-fold; epinephrine 70 %; norepinephrine
45 %. In accordance with the increase in stress biomarkers,
physical wellbeing was decreased (Schneider et al. 2008).
As one of only two such investigations of which we’re
aware, our group conducted a feasibility study on the
NASA Ames 20-G Long Arm Human Centrifuge (Fig. 3)
to determine how well humans can maintain orthostatic
tolerance during and after prolonged exposures to hyper-
gravity. A secondary objective was to examine the targeted
urinary metabolome for selected markers of oxidative
stress. Four healthy adult men, 20–34 years old, were tes-
ted during sustained 22 hour exposures in the centrifuge at
constant gravitational loads of 1.0 G (baseline) and 1.25 G.
One subject underwent additional 22-h exposure at 1.5 G
(Schmidt 2003; Toscano 2013).
Physiological data were collected continuously, which
included G-tolerance tests and measures of blood pressure,
impedance cardiography, skin conductance, skin tempera-
ture, respiration rate, and heart rate. Self-reports of mood
and symptoms, along with a cognitive performance test
were assessed at 2–4 h intervals. Serial urine samples were
collected and assayed for 8-epi-PGF2a (F2-isoprostane),
8-hydroxy-2-deoxyguanosine, malondialdehyde, 4-hy-
droxynonenal, lipid hydroperoxides, and aqueous
hydroperoxides.
Participants A, B, and C each completed the 1.25 G
exposure. One participant experienced syncope after 14 h
at 1.25 G, though he continued with the study. This small
pilot study revealed that 22-h continuous centrifugation
does not produce significant, linear changes in oxidative
markers at 1.0 and 1.25 G. However, 22-h continuous
centrifugation of a single human subject at 1.5 G resulted
in significant nausea and mood deterioration. These
symptoms were concomitant with a sharp rise in 8-epi-
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PGF2a, followed by a sudden drop. 8-epi-PGF2a is an
oxidative product of arachidonic acid and a stereoisomer of
the smooth muscle agonist PGF2a (an enzymatic product
of arachidonic acid).
This finding led us to a new hypothesis related to the
potential role of 8-epi-PGF2a in eliciting gastrointestinal
smooth muscle symptoms in various conditions of hyper-
oxia and hypoxia encountered in extreme environments
(acute mountain sickness, high altitude flight, etc.). The
study was terminated after the 1.5 G exposure, due to
potentially high risk of medical injury to the participants.
5 Moving from targeted to untargeted discovery
in AG studies
As noted, targeted studies generally involve the pre-se-
lection of a small number of analytes. For the purpose of
illustration, two analytes important to muscle metabolism
in space are briefly explored here; myostatin and PGC-1a.
Myostatin is a member of the TGFb (transforming
growth factor beta) protein family that inhibits myogenesis
(muscle differentiation and growth). In rats exposed to
17 days of microgravity on NeuroLab (NASA STS-90),
significant increases in myostatin were coupled with pro-
nounced muscle wasting (Lalani et al. 2000). Specifically,
the myostatin/beta-actin mRNA ratios were higher in the
muscles of the NeuroLab rats compared with the control
rats on earth, as follows: 5.0-fold in tibialis, 3.0-fold in
biceps, 1.9-fold in quadriceps, and 2.2-fold in gastrocne-
mius. This implicates elevated myostatin in the muscle
wasting of microgravity and space flight.
PGC-1a (peroxisome proliferator activated receptor co-
activator 1a) is referred to as the master regulator of
mitochondrial biogenesis. In addition to co-activating
PPARc, PGC-1a is also a co-regulator of NRFs and ERRa.
It thereby regulates mitochondrial biogenesis and mito-
chondrial numbers (Scarpulla 2011; Scarpulla et al. 2012).
Secretion of PGC-1a has been examined on earth during
5 weeks of unilateral limb unloading in adult humans,
wherein those in the unloading group showed a decrease in
PGC-1a expression of 36 %, compared with controls
(Fernandez-Gonzalo et al. 2014). This would seem to have
potentially significant implications for the mitochondrial
content of muscle in the space flight environment.
5.1 The human powered centrifuge example
From this and a fairly robust body of evidence, myostatin
and PGC-1a would, then, seem among the useful markers
upon which to base testing of a future AG protocol. In
general, one can envision a testing paradigm of a human
powered centrifuge (or any other AG solution) either in the
1 G environment of earth or the microgravity environment
of space. In this example, one would test various loading
conditions using the human powered centrifuge for their
effects on myostatin and PGC-1a. This would be done in
order to establish protocols optimized to those biomarkers,
along with attention to the optimized musculoskeletal
phenotype. One could extend this line of investigation to a
range of molecules and phenotypes that affect the immune
system, nervous system, cardiovascular system, and so on.
It is also important to note that, in studying the gravi-
tational ‘input’ of the HPC, attention must be given to the
atmosphere in which the gravitational exposure takes place
(the exposome). Earth based centrifugation studies are
likely to be conducted under ambient O2 and CO2 condi-
tions, unless designed otherwise. The DRMs on the ISS,
planned spacecraft, and currently envisioned space suits
call for varying composition of these gases. For instance,
Fig. 3 20 G human centrifuge at NASA Ames Research Center. The
20-G Centrifuge is capable of producing forces up to 20 times that of
terrestrial gravity, though it is human rated to 12.5 G. The maximum
g-level attainable is dependent upon the mass of the specific payload.
Mounted on the 58-foot diameter centrifuge are three enclosed cabs.
The universal rail mounting system enables novel experiment
configurations to be placed at any radius along the arm, allowing
comparison of radius, acceleration gradients, or coriolis effects. It is
rated to 50 RPM. (Image: NASA)
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the official operating range for CO2 levels on the ISS is
0.25–2.10 % (Law et al. 2010).
According to NASA, symptom reports have emerged
over the years that suggest an increased sensitivity to CO2
in microgravity and that lower limits than these (Earth
normal is 0.03 %), may be needed to prevent potential CO2
toxicity, cognitive impairment, physical performance
changes, and symptoms. Indeed, performance decrements
may turn out to be more sensitive indicators than symp-
toms. For instance, mean raw scores for seven of nine
scales of decision-making performance (basic activity,
applied activity, task orientation, initiative, information
usage, breadth of approach, and basic strategy) have shown
to consistently decline with increasing CO2 concentrations
in humans (overall p-values\0.001; Satish et al. 2012).
Therefore, in conducting AG experiments, the habitation
atmospheres one is likely to encounter in space warrant
serious consideration. Failure to address the habitation
atmosphere composition (exposome) during earth-based
AG experiments may lead to AG solutions that are not
optimally reflective of the space environment.
6 Untargeted molecular assessment (omics)
in space and on earth
One can use cardiovascular, neuromuscular, ocular, and
vestibular physiology to further illustrate this dynamic.
Each of these vital areas of aerospace medicine utilizes a
broad suite of technologies to characterize the physiologi-
cal, morphological, and behavioral responses to different
space (or test) conditions. This has led to enormous
advances in our understanding. With full respect to these
advances, we must also acknowledge that complex
molecular networks lay beneath these types of physiologic
outputs being measured and, further, that the underlying
molecular events are partially responsible for the genesis of
such physiological, morphological, and behavioral
dynamics. Omics-based analyses represent a new suite of
tools that permit comprehensive examination of this
underlying molecular landscape in relation to these
phenotypes.
We have previously asserted that omics application in
human space flight provides unique advantages in terms of
identification of novel patterns of variance, novel identifi-
cation of new countermeasure targets, and acceleration of
discovery timelines (Schmidt and Goodwin 2013). We
suggest here that the addition of omics profiling to artificial
gravity experiments represents a novel way to more
quickly understand key areas of variance in the molecular
landscape that is influenced by the variable artificial and
partial gravity conditions being tested.
Use of omics methods will help investigators detect
precise changes across broad molecular networks, as vari-
ous G-loading paradigms are applied. This will be useful in
detecting off-target, or unanticipated effects of the different
gravity paradigms applied to humans or animals. These
data-rich approaches can be used to generate new
hypotheses and to develop new potential targets of inves-
tigation. Moreover, data from such omics experiments can
be correlated with all other forms of physiologic pheno-
typing. Insights gained from these approaches may even-
tually be used to inform countermeasure development or
refine the deployment of existing countermeasures.
6.1 Untargeted molecular profiling and AG in space
Presently, there are no in-flight human or animal AG
studies that have used untargeted methods to examine the
molecular landscape. There are, however, limited cell-
based analyses that have been conducted. Disruption of
immune vigilance is an important challenge to space travel
and one representative cell-based, in-flight omics study
sheds light on potential human susceptibility to microbes in
space. In one of the only studies of its kind, Chang et al.
studied donor supplied (n = 4) human T cells, which were
stimulated with Con A and anti-CD28 on board the Inter-
national Space Station (Chang et al. 2013).
An on-board centrifuge was used to generate a 1 G
simultaneous control to isolate the effects of microgravity
from other variables of spaceflight. In the microgravity
group, 617 genes were differentially expressed compared
to on-orbit 1 G controls. Forty-seven of these genes had
2-fold or lower expression in microgravity compared to the
on-orbit 1 G control. cREL gene targets were significantly
inhibited in microgravity. The Rel/NF-jB transcription
factor family is comprised of five subunits: cRel, RelA
(p65), NF-jB-1 (p50), NF-jB-2 (p52), and RelB. Analysis
of gene connectivity indicated that this TNF-linked path-
way is a major early downstream effector pathway inhib-
ited in microgravity and may lead to ineffective host
defenses against infectious pathogens during spaceflight.
6.2 Untargeted molecular profiling and AG on earth
It has previously been shown that human embryonic kidney
cells undergo distinctly different gene expression changes
under (1) earth gravity (1 G), (2) earth gravity plus cen-
trifugation at 3 G, and (3) reduced gravity in space (0 G or
lG) (Kaysen et al. 1999); (Hammond et al. 1999, 2000)
(Fig. 4). This fundamental discovery supports the general
premise that the biological changes that occur in response
to different gravity conditions are broad and complex.
These changes in gene expression are typically
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accompanied by a changing protein (Pastushkova et al.
2013) and small molecule metabolite landscape, which can
be further characterized by proteomics and metabolomics.
An untargeted omics approach to hippocampal gene
expression has been explored in hypergravity on earth. Del
Signore et al. tested the mRNA level of about 5000 genes
in the hippocampus of mice subjected to 1.09 G (1 G) or to
1.85 G (2 G) for five repeated 1-h daily rotations in a
centrifuge (Del Signore et al. 2004; Mandillo et al. 2003).
Data were compared with those obtained for mice sta-
tionary at 1 G (C, Control). Roughly 200 genes were
affected by rotation and/or rotation ? hypergravity.
Almost all the genes affected by rotation ? hypergravity
were up-regulated, with only five being down-regulated.
The genes most influenced by the variant gravity condi-
tions code for proteins active across a range of cellular
functions (cell cycle and apoptosis, signal transduction,
neuronal structure/function, DNA/RNA metabolism, pro-
tein processing, intermediary metabolism, cytoskeleton and
motility). Six affected genes were directly or indirectly
involved in synaptic transmission and plasticity (ESTs
moderately similar to thymosin beta-10, syndet, inhibin
beta E and Ngfi-A binding protein 2, proSAAS, neurob-
lastoma ras oncogene).
A single human study further illustrates the potential
value of omics approaches to varied gravity conditions. In
this case, 12 human subjects were assigned to receive 1 G,
2 G, and 3 G exposures on a continuous (SAHC1) basis,
with 6 of those subjects being further exposed to inter-
mittent (SAHC2) artificial gravity forces, following a
recovery period. The continuous centrifugation protocol
(SAHC1) consisted of three phases, where the first and the
third phase were comprised of application of different
G-levels (1 G, 2 G, then 3 G) for 2 min each. During the
second (interim) phase, subjects were stressed with con-
tinuous exercise (Andjelic 2010).
The intermittent centrifugation protocol (SAHC2) was
also divided into three phases, wherein the first and the
third phase were identical to those of SAHC1. However, in
contrast to SAHC1, exercise stress (second phase) was
applied to test subjects intermittently over 30 min by
alternating centrifugation and rest every 3 min, which
resulted in a total of 5 cycles.
The investigators used DNA microarrays to compare
each subject’s transcriptome (the entirety of transcribed
RNA) prior to and subsequent to centrifugation at each of
the three G conditions (30,950 results). The SAHC1 tran-
script list contained 661 differentially expressed genes of
the continuous protocol of which 223 (206 ? 17) were
significantly up-regulated and 483 (342 ? 96) were sig-
nificantly down-regulated (Fig. 5). The SAHC2 transcript
list contained 243 differentially expressed genes of the
intermittent protocol, of which 63 (46 ? 17) were signifi-
cantly up-regulated and 180 (84 ? 96) were significantly
down-regulated. There were 17 common genes in both
protocols that were significantly up-regulated and 96
common genes that were significantly down-regulated. The
criteria for significance were established at p B 0.05 and
FC C 1.5 (FC, fold change).
Transcriptome data was further subjected to pathway
analysis and to biological function analysis. For instance,
one significantly up-regulated class of proteins
(p = 0.0332) was the class of antibacterial response pro-
tein, to which 5 genes were attributed. Another up-regu-
lated class of proteins (actin and actin related proteins)
was significantly affected (p = 0.0345), with 2 genes
identified. By further illustration, 2 significantly upregu-
lated genes (p = 0.0437) were found commonly associated
with two distinct receptor mediated signaling pathways:
Voltage-dependent L-type calcium channel subunit beta-2
(CACNB2) and 1-phosphatidylinositol 4,5-bisphosphate
phosphodiesterase beta-4 (PLCB4). Both are involved in
Fig. 4 Variant gene expression profiles in three gravity conditions.
The response of human embryonic kidney cells to three gravity
conditions is shown. Gene expression profiles are distinctly different,
with the microgravity condition showing the greatest variance.
Upregulated genes are shown in red, while down-regulated genes
are shown in blue. This represents the first findings from microgravity
and bioreactor experiments showing genome variance, as cells are
transitioned to the reduced gravity environment of space (Hammond
et al. 1999, 2000) (Color figure online)
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oxytocin and serotonin 5HT2 receptor mediated signaling
pathways (Andjelic 2010).
This progression from transcriptome analysis, to bio-
logical function analysis, to pathway analysis illustrates
how one can glean novel insights into the biological change
associated with the different AG paradigms, which can be
used to further refine all forward experimental design and
countermeasure development efforts.
We undertook a pilot study (NASA HRI-246) to deter-
mine the practicality of using the NASA Ames 20 G long
arm (27.36 ft., 8.8 m) and short arm (8.36 ft., 2.5 m)
centrifuge to quantify effects of different G levels, radii,
and their resulting gravity gradients on body fluid distri-
bution, cardiovascular regulatory responses, and the effect
of lower limb exercise (Fig. 3). We also evaluated two
plasma specimens (baseline and endpoint) from three
subjects under three separate hypergravity conditions to
evaluate experimental design elements related to conduct-
ing metabolomics analysis on a very small subject popu-
lation (Schmidt and Howarth 2007; Howarth 2014).
The conditions included, Condition A: Short Radius
(1–1.25 G) No Exercise (Legs Extended); Condition C:
Long Radius (1–1.25 G) No Exercise (Legs Extended);
Condition H: Long Radius (1–2.5 G) Legs Up (Variable
Exercise). The metabolomics portion of the study gener-
ated roughly 16,000 molecular features, which were eval-
uated using principal component analysis. The only
condition showing any baseline to endpoint trend was in
the three subjects, during the Long Radius-Variable Exer-
cise paradigm, though these results must be taken with
caution due to small subject numbers. The study clearly
illustrated the unique challenges of small subject and large
variable numbers encountered in space-related omics
studies, and highlighted the special consideration that must
be given to experimental design in such research.
7 Omics sub-disciplines applied to the AG
environment
Each of the primary omics disciplines below has the
capacity to reveal unique patterns of molecular variance in
AG experiments, which can inform countermeasure
parameters. Note that the examples below reflect single
target molecules, but they are used to illustrate the types of
markers that can be generated, as part of untargeted anal-
yses applied within any given AG context.
7.1 Genomics
Assess the DNA exome, including single nucleotide poly-
morphisms, copy number variants, insertions, and dele-
tions. SNPs can inform investigators about susceptibility to
various G conditions and aid in determination of whether
there is an optimum or limiting genotype (single genes or
clusters of genes) for a given G condition. Example: the
brain-derived neurotrophic factor (BDNF) Val66Met vari-
ant may influence cognitive function, psychological cop-
ing, or neuronal repair (Zuccato and Cattaneo 2009;
Soliman et al. 2010).
7.2 Epigenomics
Transcriptomic regulating factors not empirically coded in
the genomic sequence. Epigenome patterns under various
G-conditions may aid in identification of gene regulating
effects that impact the AG response (Casey et al. 2015).
Example: methylation of the BDNF promoter may be
detrimental to neural function in astronauts under the stress
of space (Kang et al. 2013), while methylation of the PGC-
1a promoter may affect muscle, bone, brain, heart, and
other tissues in space (Barre`s et al. 2009).
7.3 Transcriptomics
Assessment of gene expression through RNA transcripts.
Gene expression patterns under various G-conditions may
aid in detecting different patterns of change over time. This
may yield new potential assessment targets and lead to new
countermeasure targets. Example: varied expression of IL-
1b or TNFa may result in altered immune function in space
(Crucian et al. 2014).
7.4 Proteomics
Assessment of protein expression. Protein expression pat-
terns under various G-conditions may aid in optimizing the
AG parameters. Example: elevated myostatin protein is
associated with muscle wasting and contributes to the
Fig. 5 Venn diagram of transcriptome response to continuous and
intermittent centrifugation in humans. Up-regulated and down-
regulated genes are shown for the continuous (SAHC1; continuous
centrifugation protocol; n = 12) and intermittent (SAHC2; intermit-
tent centrifugation protocol; n = 6) centrifugation protocols.
p B 0.05 and FC C 1.5 (Adapted from Andjelic 2010) (Color
figure online)
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atrophic effects of glucocorticoids on skeletal muscle
(Schakman et al. 2013).
7.5 Metabolomics
Assessment of the small molecule pool (below 1500 amu).
Metabolite patterns may reveal changes across metabolic
networks under varied G conditions. Example: altered
lipidome may provide broad information related to sig-
naling cascades, dietary influences on the AG response,
inflammatory pathways, and putative cell membrane
composition (Montoliu et al. 2014).
7.6 Exposomics
Assessment of the exposome. The exposome is the sum of
environmental exposures and the response to those expo-
sures (Wild 2012; Miller and Jones 2014; Miller 2014). In
space flight, an important aspect of the exposome is the
percent composition and partial pressure of gases that
comprise the habitation and exploration atmospheres, such
as CO2 and O2. The full complement of integrated omics
can be used to describe the human response to these
exposures. Example: elevated habitation carbon dioxide
has been associated with decrements in multiple scales of
decision making, such as task orientation, focused activity,
initiative, applied activity, and information usage (Satish
et al. 2012).
7.7 Metallomics
Assessment of the entirety of metals and metalloids within
a cell or tissue type (Szpunar 2005; Mounicou et al. 2009).
Broadly speaking, metallomics is the study of the metal-
lome, interactions, and functional connections of metal
ions and other metal species with genes, proteins,
metabolites, and other biomolecules in biological systems
(Lobinski et al. 2010). A specific example of how metal-
lomics may be deployed as an ‘experimental artificial
gravity sensor’ is outlined below.
8 Omics analysis as an ‘‘experimental artificial
gravity sensor’’
As noted, determining the appropriate artificial gravity
condition is among the more daunting challenges facing
AG investigators. One aspect of this challenge derives from
selecting the ideal combination of phenotypic elements on
which to base the decision of which gravity condition is
ideal for astronauts.
Since loss of muscle is one of the key reasons for
deployment of artificial gravity, muscle represents a useful
tissue for determination of the appropriate AG condition. It
is important to recognize, however, that muscle turns over
slowly and sensitive surrogate molecular measures of
muscle may be additionally useful.
Magnesium is easily the most widespread metal ion
cofactor found in enzymatic systems (Cowan 2002). This is
principally related to the ability of Mg2? to form
stable complexes with phosphate-containing species in
physiologic systems, such as muscle (Sissi and Palumbo
2009).
Studies from the International Space Station (ISS) have
previously shown that urinary Mg levels were 44 % lower
after landing than before launch (p\ 0.001). Specifically,
55 % of ISS crew members had Mg concentrations lower
than the low end of the clinical range (3.0 mmol/d) (Smith
et al. 2005a, b). Moreover, after six months in space, there
is a loss of Mg reservoirs, with 35 % loss in some leg
muscles (Fitts et al. 2010). This is noteworthy, as muscle
and bone are the principal reservoirs for Mg in the human
body, accounting for 27 % and 53 % of total body Mg,
respectively (Keller 1991).
A recent paper (Smith and Zwart 2015) endeavored to
address selected aspects of the Mg and space flight ques-
tion. While it did not attempt to address the impact of Mg
on DNA (see below), it did highlight the need for sub-
stantially more research on the trajectory of tissue mag-
nesium stores in astronauts on long duration missions. The
space flight-induced loss of Mg from its reservoirs renders
magnesium a potentially useful surrogate marker that is
related to the muscle response in altered gravity. One can
envision close monitoring of the magnesium trajectory
during AG experiments as a specific and, potentially,
sensitive measure of the muscle response to gravitational
loads. Beyond Mg, one can further envision assessment of
the metallome, as a broader measure of the response to
varied AG conditions. In this context, the metallome may
be viewed as one potential ‘experimental artificial gravity
sensor’ that may inform the refined assessment of any
given AG parameter under investigation.
8.1 Gravity, radiation, and the metallome
When considering the artificial gravity question, it is rea-
sonable that we also consider an important, converging
variable simultaneously encountered in the space environ-
ment—radiation. While changing muscle Mg dynamics
(and, perhaps, the metallome in general) in altered gravity
is potentially revealing, the changing Mg pool may also
impact how astronauts respond to radiation. To better
understand the implications of this, it is important to
review the central role of Mg in DNA repair and view this
in the context of space radiation exposure.
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We have previously raised concerns that magnesium
loss associated with space flight may reduce DNA repair at
a time when efficient DNA repair is most needed—in the
high radiation environment of space (Schmidt and Good-
win 2013). This is based on three fundamental roles of
magnesium in DNA repair, including (1) as a catalytic
center of numerous DNA repair enzymes, (2) as the key
trace element that stabilizes all ADP and ATP molecules
(ATP being required for DNA repair), and (3) as a core
element in ATP synthase.
With specific reference to ATP, Magnesium bound to
ATP is the sole biologically active form of ATP found in
humans (wherein Mg is bound to the phosphate groups of
ADP and ATP, as MgATP2-). Moreover, Mg2? is a central
ion in ATP synthase, binding to phosphate in the catalytic
F1 moiety of ATP synthase.
Magnesium is an essential cofactor in almost all enzy-
matic systems involved in DNA processing, with a stabi-
lizing effect on DNA and chromatin structure (Hartwig
2001). In general, magnesium cations bind to DNA and
reduce the negative charge density, thereby stabilizing the
structure of DNA (Anastassopoulou and Theophanides
2002). Magnesium is an essential cofactor for enzyme
systems involving DNA repair, such as mismatch repair,
base excision repair, nucleotide excision repair, and dou-
ble-strand break repair (Hartwig 2001; Nishino and Mor-
ikawa 2002).
For example, Apurinic/apyrimidinic endonuclease 1
(APE1) is a powerful enzyme that absolutely requires
Mg2? and is the major AP endonuclease in mammalian
cells (Manvilla et al. 2013). Previous studies have shown
that the robust APE1 activity can be fully suppressed by
rigorous chelation of Mg2? (Erzberger and Wilson, 1999;
Maher and Bloom 2007), suggesting that Mg2? is essential
for APE1 activity and DNA repair. In general, APE1
hydrolyzes the phosphodiester bond at abasic sites, pro-
ducing 50-deoxyribose phosphate (dRP) and the 30-OH
primer needed for repair synthesis. APE1 also mediates the
repair of single-strand and double-strand breaks by
removing blocking groups, such as fragmented sugar
moieties (Manvilla et al. 2013).
DNA ligase I (LIG1) catalyzes the ligation of single-
strand breaks to complete DNA replication and repair. The
energy of ATP is used to form a new phosphodiester bond
in DNA via a reaction mechanism that involves three dis-
tinct Mg2?-dependent chemical steps. At saturating con-
centrations of ATP and Mg2? ions, the three chemical steps
occur at similar rates, and the efficiency of DNA ligation is
high. However, under conditions of reduced Mg2?, the
nick-sealing step becomes rate-limiting, which may sig-
nificantly compromise DNA replication and repair (Taylor
et al. 2011).
Topoisomerases are DNA backbone-processing
enzymes. They produce a topological change in a DNA
chain by the unwinding or the supercoiling of the double
helix (Champoux 2001). This releases the torsional strain
imposed by DNA processing (Schoeffler and Berger 2008).
Topoisomerases frequently require cofactors for their full
catalytic activity. ATP (as MgATP2-) regulates the con-
formational changes required for enzyme action through
binding and hydrolysis processes. Thus, divalent Mg2? is
required for catalytic and for structural functions, while
also forming complexes with ATP. In both topoisomerase
IA and topoisomerases II, the Mg2? ions are tightly
anchored to the protein backbone through four carboxyl
side chain residues (Asp, Glu) (Sissi and Palumbo 2009).
Beyond the specific examination of magnesium and the
general examination of the metallome, broader omics
methods may be used to survey other molecular features
that may serve as ‘experimental artificial gravity sensors.’
This is the landscape on which unpredictable patterns of
variance associated with a given gravity condition may be
revealed.
A final illustration of this potential can be found in the
work of Caiozzo et al. (2009). Male participants
(29 ± 3 year) were subjected to 21 days of 6 head-down
tilt bed rest (BR group; n = 7) and compared to those on
21 days of bed rest, plus daily exposure to 1 h bouts of
2.5 Gz (as measured at the feet; AG group; n = 8).
Twenty-one days of bed rest produced a 20 % reduction
in muscle fiber cross-sectional area in the soleus muscle,
whereas it was unchanged in the AG group. This was
accompanied by a trend of elevated mRNA levels of
myostatin (p = 0.09) and atrogin (p = 0.12) in the BR
group, consistent with a muscle catabolic state. In contrast,
AG was effective in maintaining muscle structure and
function in plantar flexors.
While AG resulted in positive phenotypic changes in
muscle structure and function, it was not sufficient to
prevent losses in slow-to-fast isoform myosin heavy chain
(MHC) mRNA isoform transitions and losses in total MHC
mRNA levels. Bed rest produced significant reductions
(*35 %) in the total MHC mRNA levels in both the soleus
and the vastus lateralis muscles. However, the actin mRNA
levels were unaffected in either muscle, leading the authors
to suggest that the transcriptional regulation of myosin is
much more sensitive to loading state than is actin (Caiozzo
et al. 2009).
Such findings make a compelling case that broad omics
analysis of the molecular landscape may yield more sen-
sitive and early indicators of the biological response to AG
than the standard physiologic, morphologic, and behavioral
phenotype that is typically measured. At minimum, omics
analysis can be expected to provide additional molecular
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features and greater precision in determining the optimal
application of AG.
8.2 Hypothetical AG metabolomics experiment
in space
The Rodent Centrifuge Facility being deployed on the ISS
by NASA can be used to illustrate the use of metabolomics
in studying artificial gravity in space (Fig. 6). In this
hypothetical study design, animals would be exposed to
centrifugation at 0.66 G and 1.0 G (though, under a real
experimental scenario, one might also include 0.16 G
(Lunar) and 0.38 G (Mars) AG conditions). Duration
would be explored by exposing groups to 12 and 24 h of
centrifugation each day. These animals would be compared
with microgravity controls (lG).
Because of the typical small animal numbers used in
such studies, serial measures are recommended in order to
develop longitudinal trajectories. These paradigms would
be compared over 30 days. Both targeted and untargeted
metabolomics would be used, in order to capture known
and exploratory analytes.
Analytical platforms, such as LC–MS–MS, GC–MS–
MS, and NMR would be employed to identify and quan-
titate the different molecular forms. Both univariate and
multivariate statistics would be used in order to detect
variance, determine significance, and identify pathways of
interest. This would form the foundation of biological
function analysis. A similar model can be used for human
AG experimentation in space or on earth, as technology
permits.
9 Future considerations
The Artificial Gravity Working Group and the affiliated
scientific community can benefit from various investigators
and teams with know-how in specific omics disciplines.
Moreover, various omics-related societies, such as the
Metabolomics Society (and others), have recommended
standards related to some of the unique experimental issues
involved in gathering omics data. This ranges from
addressing challenges in experimental design to those of
statistical approaches (Dunn et al. 2011; Broadhurst and
Kell 2006) that warrant consideration in order to optimize
the potential for meaningful discovery involving small
subject and large variable numbers.
Our general enthusiasm for collaboration intersects with
a conundrum, which derives from a distressed people
versus time relationship. The AG research community
tasked with asking and answering the seminal AG ques-
tions is relatively small. Moreover, these studies are
dependent upon access to centrifugation that can be applied
to humans and other mammals, under Earth or space
conditions. The time lines are also very short for upcoming
human missions that include the Moon and Mars. It is
perhaps more accurate to say that there is an unusual
urgency to this matter, which can be partially addressed by
Fig. 6 Hypothetical design of an AG metabolomics experiment in space, using the rodent centrifuge facility
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the convergence of investigator teams from omics disci-
plines with those of the artificial gravity discipline.
Given the paucity of molecular data from space flight
AG experiments and the need for more robust molecular
data from earth-based AG studies, one could argue that we
must do everything we can to gather the greatest depth and
breadth of molecular data possible—something that can be
aided by omics experiments. Moreover, many AG experi-
ments are unusually difficult to design and execute. Using
only targeted physiologic, behavioral, or morphological
phenotyping does not take full advantage of the consider-
able effort waged to develop this rare and complex
experimental condition.
We invite the scientific community to consider the fol-
lowing path forward for all future AG experiments,
regardless of the experimental condition. First, we recom-
mend designing all artificial gravity experiments in such a
way that appropriate specimens for omics investigations
can be captured. The design of such experiments could be
done in collaboration with the omics community in order to
minimize experimental variance, optimize detection of true
biological variance, and avoid false discoveries. Second,
we suggest investigators biobank these specimens accord-
ing to current best practices, either for immediate analysis
or as archival specimens for future analysis.
Such an approach would be expected to provide more
robust data sets, valuable in refining ideal mission AG
parameters. This approach may also yield unexpected
countermeasure targets, leading to adjunct solutions that
could be used to augment any chosen AG parameters. In
our view, this represents a unique opportunity to signifi-
cantly advance one of the key elements supporting the
sustained presence of humans in space.
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